Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERAP2 | Q6P179 | 2/20 | 0.58 |
| ▸ | LNPEP | Q9UIQ6 | 2/20 | 0.58 |
| ▸ | GNPAT | O15228 | 1/20 | 0.54 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.53 |
| ▸ | MMP2 | P08253 | 1/20 | 0.51 |
| ▸ | OPRD1 | P41143 | 5/20 | 0.50 |
| ▸ | OPRM1 | P35372 | 4/20 | 0.50 |
| ▸ | REN | P00797 | 1/20 | 0.49 |
| ▸ | ECE1 | P42892 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31528348 | 1.00 | ERAP2 (0.58) | ERAP2LNPEPGNPATOPRK1MMP2 | |
| SCHEMBL31181266 | 0.97 | GNPAT (0.59) | ERAP2LNPEPGNPATOPRK1OPRD1 | |
| SCHEMBL30497071 | 0.96 | GNPAT (0.58) | ERAP2LNPEPGNPATOPRK1OPRD1 | |
| SCHEMBL30407529 | 0.93 | OPRK1 (0.56) | ERAP2LNPEPGNPATOPRK1OPRD1 | |
| SCHEMBL170652 | 0.93 | ERAP2 (0.65) | ERAP2LNPEPGNPATOPRK1MMP2 | |
| SCHEMBL1711485 | 0.93 | ERAP2 (0.65) | ERAP2LNPEPGNPATOPRK1MMP2 | |
| SCHEMBL28540087 | 0.93 | ERAP2 (0.65) | ERAP2LNPEPGNPATOPRK1MMP2 | |
| SCHEMBL29372662 | 0.93 | ERAP2 (0.65) | ERAP2LNPEPGNPATOPRK1MMP2 | |
| SCHEMBL29382413 | 0.93 | ERAP2 (0.65) | ERAP2LNPEPGNPATOPRK1MMP2 | |
| SCHEMBL9747671 | 0.93 | ERAP2 (0.65) | ERAP2LNPEPGNPATOPRK1MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2249 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230310641-A1 | Site-specific antibody conjugation and its use | HOFFMANN-LA ROCHE INC. (US) | 2023-10-05 | — | — | US | claimed |
| CN-112457401-B | Molecular imaging probe for diagnosing multiple myeloma | 上海交通大学医学院附属仁济医院 | 2023-02-24 | — | — | CN | claimed |
| CN-114080232-B | Extracellular vesicles for vaccine delivery | Lhasa Sales Co.,Ltd. (CH) | 2026-05-26 | — | — | CN | disclosed |
| CN-113853432-B | Novel polypeptides for producing patchoulol and/or drimenol compounds | 弗门尼舍有限公司 | 2026-05-15 | — | — | CN | disclosed |
| CN-115335392-B | Inhibition of shade-avoidance response in plants | 成对植物服务股份有限公司 | 2026-05-15 | — | — | CN | disclosed |
| CN-112752837-B | Natural killer cells | 帝国理工学院创新有限公司 | 2026-05-15 | — | — | CN | disclosed |
| CN-116023447-B | BmoR mutant-based wide-area biosensor | 北京理工大学 | 2026-02-27 | — | — | CN | disclosed |
| US-12534715-B2 | Nucleic acids for nuclease-mediated genome editing | WAGENINGEN UNIVERSITEIT (NL) | 2026-01-27 | — | — | US | disclosed |
| EP-4656723-A1 | LUCIFERASE VARIANT | Kikkoman Corporation (JP) | 2025-12-03 | — | — | EP | disclosed |
| US-12486333-B2 | Tissue plasminogen activator antibodies and method of use thereof | EMSTOPA LIMITED (GB) | 2025-12-02 | — | — | US | disclosed |
| EP-4626453-A1 | PEPTIDE WITH ANTI-INFLAMMATORY AND ANTI-MICROBIAL ACTIVITY | Isanaka, Ramakrishna Reddy (IN) | 2025-10-08 | — | — | EP | disclosed |
| CN-113993989-A | Process for producing ergothioneine | 丹麦科技大学 | 2022-01-28 | — | — | CN | disclosed |
| CN-113980920-A | Carbon-carbon double bond reductase and application thereof | 湖南正清制药集团股份有限公司 | 2022-01-28 | — | — | CN | disclosed |
| CN-113993541-A | Alkaline phosphatase-based oncology therapy | 合成生物制品有限公司 | 2022-01-28 | — | — | CN | disclosed |
| CN-113980881-A | Streptomyces fungicidicus engineering bacterium for high yield of enramycin | 枣庄市杰诺生物酶有限公司 | 2022-01-28 | — | — | CN | disclosed |
| CN-113969269-A | D-amino acid oxidase mutant and application thereof in preparation of L-glufosinate-ammonium | 永农生物科学有限公司 | 2022-01-25 | — | — | CN | disclosed |
| CN-113969268-A | Glu/Leu/Phe/Val dehydrogenase mutant and application thereof in preparation of L-glufosinate-ammonium | 永农生物科学有限公司 | 2022-01-25 | — | — | CN | disclosed |
| CN-110713991-B | Application of carbonyl reductase and mutant thereof in synthesis of indacaterol drug intermediate | 中国科学院天津工业生物技术研究所 | 2022-01-25 | — | — | CN | disclosed |
| CN-113957088-A | Artificial design and application of intercellular communication system | 中国科学院微生物研究所 | 2022-01-21 | — | — | CN | disclosed |
| CN-113957061-A | Administration of kynurenine depleting enzymes for tumor therapy | 得克萨斯大学体系董事会 | 2022-01-21 | — | — | CN | disclosed |